Domov › Sladkorna bolezen tipa 1 › Pennsylvania
Klinične študije za Sladkorna bolezen tipa 1 v Pennsylvania
13 študij za Sladkorna bolezen tipa 1 išče udeležence na lokacijah v Pennsylvania.
Mesta v Pennsylvania
Uradno besedilo študije (angleško)
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Children's Hospital of Philadelphia (CHOP), Philadelphia
Vključevanje udeležencevFaza 3
Starost 1–35 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07222137A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
Vključevanje udeležencevFaza 3
Starost 1–35 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07222332A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- The Children's Hospital of Philadelphia- Site Number : 8400039, Philadelphia
Vključevanje udeležencevFaza 3
Starost 1–25 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07088068Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- University of Pittsburgh, Pittsburgh
Vključevanje udeležencevFaza 2
Starost 4–34 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- University of Pittsburgh, Pittsburgh
Vključevanje udeležencevFaza 2
Starost 8–45 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Pittsburgh, Pittsburgh
Vključevanje udeležencevFaza 1/2
Starost 9–20 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07061574A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center Montefiore, Pittsburgh
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT04786262SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- The Children's Hospital of Philadelphia, Philadelphia
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Vključevanje udeležencevFaza 2
Starost 5–40 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Pennsylvania, Philadelphia
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 16. jul. 2026 · NCT06880835Registry for Stage 2 Type 1 Diabetes
- Hospital of The University of Pennsylvania- Site Number : 8400021, Philadelphia
- The Children's Hospital of Philadelphia- Site Number : 8400029, Philadelphia
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 13. apr. 2026 · NCT06481904An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Perelman Center for Advanced Medicine - Endocrinology, Philadelphia
- Montefiore Clinical and Translational Research Center - Endocrinology, Pittsburgh
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 23. mar. 2026 · NCT06832410Closed Loop and Education for Hypoglycemia Awareness Restoration
- University of Pennsylvania, Philadelphia
Vključevanje udeležencev
Starost 18–75 · Vsi spoli · Posodobljeno 3. mar. 2026 · NCT06325202TrialNet Pathway to Prevention of T1D
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 2–45 · Vsi spoli · Posodobljeno 1. jul. 2025 · NCT00097292Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.